Protopanaxatriol ameliorates diabetic retinopathy by regulating mTOR/G6PD mediated pentose phosphate pathway

Newman DK (2010) Surgical management of the late complications of proliferative diabetic retinopathy. Eye 24:441–449. https://doi.org/10.1038/eye.2009.325

Article  CAS  PubMed  Google Scholar 

Everett LA, Paulus YM (2021) Laser therapy in the treatment of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 21:35. https://doi.org/10.1007/s11892-021-01403-6

Article  PubMed  PubMed Central  Google Scholar 

Sun JK, Glassman AR, Beaulieu WT, Stockdale CR, Bressler NM, Flaxel C, Gross JG, Shami M, Jampol LM (2019) Rationale and application of the protocol s anti-vascular endothelial growth factor algorithm for proliferative diabetic retinopathy. Ophthalmology 126:87–95. https://doi.org/10.1016/j.ophtha.2018.08.001

Article  PubMed  Google Scholar 

Wang YR, Sun X, Xie YM, Du A, Chen M, Lai SS, Wei XH, Ji LL, Wang CH (2024) Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: association with the NF-κB signaling pathway. J Ethnopharmacol 319:117135. https://doi.org/10.1016/j.jep.2023.117135

Article  CAS  PubMed  Google Scholar 

Zhou P, Xie WJ, Meng XB, Zhai YD, Dong X, Zhang XL, Sun GB, Sun XB (2019) Notoginsenoside R1 ameliorates diabetic retinopathy through PINK1-dependent activation of mitophagy. Cells 8:213. https://doi.org/10.3390/cells8030213

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan CL, Qiao Y, Tang MK (2017) Notoginsenoside R1 attenuates high glucose-induced endothelial damage in rat retinal capillary endothelial cells by modulating the intracellular redox state. Drug Des Dev Ther 11:3343–3354. https://doi.org/10.2147/dddt.S149700

Article  CAS  Google Scholar 

Dong CX, Liu P, Wang HZ, Dong M, Li GX, Li YB (2019) Ginsenoside Rb1 attenuates diabetic retinopathy in streptozotocin-induced diabetic rats. Acta Cir Bras 34:e201900201. https://doi.org/10.1590/s0102-8650201900201

Article  PubMed  PubMed Central  Google Scholar 

Xue LP, Hu M, Li JJ, Li YD, Zhu Q, Zhou GL, Zhang XF, Zhou Y, Zhang JY, Ding P (2022) Ginsenoside Rg1 inhibits high glucose-induced proliferation, migration, and angiogenesis in retinal endothelial cells by regulating the lncRNA SNHG7/miR-2116-5p/SIRT3 axis. J Oncol 2022:6184631. https://doi.org/10.1155/2022/6184631

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang SN, Ju ZC, Guan HD, Yu L, Wang ZT, Zhao YQ (2019) Dose-dependent exposure profile and metabolic characterization of notoginsenoside R(1) in rat plasma by ultra-fast liquid chromatography-electrospray ionization-tandem mass spectrometry. Biomed Chromatogr 33:e4670. https://doi.org/10.1002/bmc.4670

Article  CAS  PubMed  Google Scholar 

Li XQ, Li L, Liu XF, Liu JH (2017) Metabolism of saponins of Panax notoginseng by human intestinal microflora in vitro. Pharm Biotechnol 24:218–223. https://doi.org/10.19526/j.cnki.1005-8915.20170306

Article  Google Scholar 

Guo ZQ, Gao LC, Chen F, Ma YB, Han L (2018) Research progress on preparation methods and pharmacological activity of 20 (S) -protopanaxadiol. World Latest Med Inform 18:26–27. https://doi.org/10.19613/j.cnki.1671-3141.2018.62.011

Article  Google Scholar 

Chen XL, Shi DZ, Si RH, Liu JP, Li PY (2021) Research progress on the biological activity and mechanism of Protopanaxatriol. J Liaoning Univ Tradit Chin Med 23:209–214. https://doi.org/10.13194/j.issn.1673-842x.2021.02.047

Article  CAS  Google Scholar 

Xie JQ, Li YH, Liang YL, Kui HQ, Wang C, Huang JM (2023) Integration of non-targeted metabolomics with network pharmacology deciphers the anxiolytic mechanisms of Platycladi Semen extracts in CUMS mice. J Ethnopharmacol 315:116571. https://doi.org/10.1016/j.jep.2023.116571

Article  CAS  PubMed  Google Scholar 

Zhang J, Xie JQ, Liang YL, Li YH, Zhang YC, Wang C, Huang JM (2022) Anxiolytic effects, metabolism and plasma pharmacokinetics of 3, 6’-disinapoylsucrose. Biomed Pharmacother 149:112913. https://doi.org/10.1016/j.biopha.2022.112913

Article  CAS  PubMed  Google Scholar 

Lei Y, Xie JQ, Xie ZS, Zhao X, Wang CJ, Huang JM (2025) Comparative drug-drug interactions of Berberine and Astragaloside IV in normal and type 2 diabetes mellitus rats based on UPLC-QqQ-MS/MS. Acta Mater Med 4:51–69. https://doi.org/10.15212/AMM-2024-0078

Article  CAS  Google Scholar 

Lee Y, Yang J (2021) Development of a zebrafish screening model for diabetic retinopathy induced by hyperglycemia: reproducibility verification in animal model. Biomed Pharmacother 135:111201. https://doi.org/10.1016/j.biopha.2020.111201

Article  CAS  PubMed  Google Scholar 

Jung SH, Kim YS, Lee YR, Kim JS (2016) High glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: a short-term animal model of diabetic retinopathy. Br J Pharmacol 173(1):15–26. https://doi.org/10.1111/bph.13279

Article  CAS  PubMed  Google Scholar 

Wang C, Wang Y, Ma SR, Zuo ZY, Wu YB, Kong WJ, Wang AP, Jiang JD (2019) Berberine inhibits adipocyte differentiation, proliferation and adiposity through down-regulating galectin-3. Sci Rep 9:13415. https://doi.org/10.1038/s41598-019-50103-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang C, Cheng YY, Zhang YH, Jin HT, Zuo ZY, Wang AP, Huang JM, Jiang JD, Kong WJ (2021) Berberine and its main metabolite berberrubine inhibit platelet activation through suppressing the class i PI3Kβ/Rasa3/Rap1 pathway. Front Pharmacol 12:734603. https://doi.org/10.3389/fphar.2021.734603

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan ZS, Tian Y, Zhang C, Wang MS, Xie JQ, Wang C, Huang JM (2023) Integration of systematic review, lipidomics with experiment verification reveals abnormal sphingolipids facilitate diabetic retinopathy by inducing oxidative stress on RMECs. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1868:159382. https://doi.org/10.1016/j.bbalip.2023.159382

Article  CAS  PubMed  Google Scholar 

Wang C, Yuan ZS, Xie JQ, Lei Y, Li YH, Huang JM, Kong WJ, Jiang JD (2023) Integrated metabolomics and molecular docking reveal berberrubine inhibits thrombosis by regulating the vitamin K catalytic cycle in mice. Eur J Pharmacol 938:175436. https://doi.org/10.1016/j.ejphar.2022.175436

Article  CAS  PubMed  Google Scholar 

Yu X, Wu H, Zhou L, Wang G, Sun X, Miao J, Ben M, Shi R, Wan S, Li S, Wang X, Zhou X, Zhao Y (2025) Ameliorative effect and potential mechanism of hyperoside on diabetic retinopathy. Front Endocrinol (Lausanne) 16:1556310. https://doi.org/10.3389/fendo.2025.1556310

Article  PubMed  PubMed Central  Google Scholar 

Zhou L, Zhang T, Lu B, Yu Z, Mei X, Abulizi P, Ji L (2016) Lonicerae japonicae flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis. J Ethnopharmacol 189:117–125. https://doi.org/10.1016/j.jep.2016.05.039

Article  CAS  PubMed  Google Scholar 

Sun K, Chen Y, Zheng S, Wan W, Hu K (2024) Genipin ameliorates diabetic retinopathy via the HIF-1α and AGEs-RAGE pathways. Phytomedicine 129:155596. https://doi.org/10.1016/j.phymed.2024.155596

Article  CAS  PubMed  Google Scholar 

Deng XQ, Zhao JQ, Qu LL, Duan ZG, Fu RZ, Zhu CH, Fan DD (2020) Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer. Biochem Pharmacol 178:114038. https://doi.org/10.1016/j.bcp.2020.114038

Article  CAS  PubMed  Google Scholar 

Li YH, Liang YL, Xie JQ, Wang C, Huang JM (2024) Research progress on biotransformation of saponins from traditional Chinese medicine. Chin Tradit Herb Drugs 55:989–1003. https://doi.org/10.7501/j.issn.0253-2670.2024.03.029

Article  CAS  Google Scholar 

Deng JJ, Liu Y, Duan ZG, Zhu CH, Hui JF, Yu M, Ma P, Ma XX, Fan DD, Yang HX (2017) Protopanaxadiol and Protopanaxatriol-type saponins ameliorate glucose and lipid metabolism in type 2 diabetes mellitus in High-Fat Diet/Streptozocin-Induced mice. Front Pharmacol 8:506. https://doi.org/10.3389/fphar.2017.00506

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif